by Simona Gilman | Jan 6, 2020 | News, Uncategorized
“The company Hill runs, GNS Healthcare, found a genetic signature in some multiple myeloma patients that suggested they would benefit from a transplant. For others, the risky, painful, and expensive procedure would probably only provide false hope.” Read...
by wpengine | Oct 6, 2018 | Uncategorized
Iya Khalil, Co-Founder and Chief Commercial Officer at GNS Healthcare, sat down with the Center for Data Innovation’s Joshua New to answer five questions about GNS, causal machine learning, and AI trends. New asked about the increased utility of AI in healthcare and...
